Search results for: 'm9de fuel develop deceleration'

Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...

29 Oct 2020  |  North America  |  Market Research

Technology Innovations and Evolving Standard of Care Fueling Growth of the Global Hemodynamic Monitoring Systems Market, 2025

Increased Competitive Intensity Driving Transformational Growth through M&A, Innovative Business Models, and New Product Development

Infographics

×

Hemodynamic monitoring aims to guide medical management of critically ill patients who are prone to hemodynamic instability. It performs the function of assessing the blood volume and oxygen perfusion, along with other parameters, to prevent or treat organ failure and improve the outcomes for patients. This study aims to analyze and forecast the m...

Non-alcoholic steatohepatitis (NASH) is a chronic liver condition whose prevalence across the globe continues to rise year on year. The liver disorder is considered very dangerous as its symptoms can be mistaken for other liver disorders and conditions. Moreover, the disease can quickly progress to result in liver failure for the patients. The incr...

12 Aug 2020  |  North America  |  Market Research

New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025

AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities

Infographics

×

Key Issues Addressed

Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...

29 Jun 2020  |  Global  |  Technology Research

Decoding Technological Advances in Biomanufacturing

Growing Viral Vector Contract Development Manufacturing Landscape

Infographics

×

The rise in gene therapies over the last few years has created a huge opportunity for viral vector Contract Research Development Organization (CMO/CDMO) to fill the gap of high demand and shortage of viral vectors. As of January 2020, the US Food and Drug Administration FDA has approved four gene therapies and claims to have over 900 therapies i...

Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...

Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurri...

High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditu...

The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...